Radboud University Medical Center Becomes First Hospital in the Netherlands to Win HIMSS Stage 7 Award

HIMSS EuropeHIMSS Analytics Europe, subsidiary of HIMSS Europe, has awarded Radboud university medical center with the Stage 7 Award, making it the first HIMSS Stage 7 hospital in the Netherlands and the third in Europe.

The hospital, which has 953 beds, joins the University Medical Centre Hamburg-Eppendorf in Germany and the Hospital de Dénia-Marina Salud in Spain in the highest stage of the European EMR Adoption Model (EMRAM) developed by HIMSS.

The Netherlands enjoy a high number of Stage 6 awarded hospitals, which consolidates this country as one of the European leaders in ehealth. Beside Radboudumc, as of today, 10 Dutch hospitals and university medical centers have achieved Stage 6. Across Europe there are more than 50 hospitals recognized in the Stage 6 category.

EMRAM has been adapted to meet the needs of European healthcare institutions as a methodology for evaluating the progress and impact of electronic medical record systems in hospitals. Tracking their progress in completing eight stages (0‐7), hospitals can review the implementation and utilization of information technology applications with the aim of reaching Stage 7, which represents a superior electronic patient record environment.

Hospitals that reach Stage 7 support the true sharing and use of patient data to improve process performance, quality of care and patient safety. Uwe Buddrus, senior consultant at HIMSS Analytics Europe, said: "Radboudumc is only the third hospital in Europe to achieve the prestigious HIMSS EMRAM Stage 7 Award and the first within two years during which many European hospitals - more than 1100 in Europe, 62 of which in The Netherlands - participated in the EMRAM evaluation. I am very happy that HIMSS has identified another best practice example in Europe, which I am sure will stimulate many other hospitals on their journey towards improving healthcare delivery by the use of hospital IT solutions."

Buddrus adds: "Radboudumc is also the first fully approved member of the HIMSS Stage 6 & 7 Club, and expected to take a leading role in providing continuous evidence of the benefits of IT. Among the many highlights of Radboudumc's achievements since its last evaluation and recognition as Stage 6, I'd like to emphasize their approach towards medication safety, as well as Clinical Decision Support."

For more information on the stage 7 award visit http://himssanalytics.eu/emram/

About HIMSS Analytics Europe
HIMSS Analytics Europe (HAE) provides health care organisations, governments and industry with extensive data resources and services about the adoption and use of healthcare information technology in Europe. HAE’s offerings include comparative Hospital IT adoption benchmarking, a European‐formulated EMR Adoption Model (EMRAM) scale, and other resources to help hospital directors, IT executives and clinicians compare and measure their progress and how they compare to others. Country level and application specific reports also provide insights into major IT adoption trends and applications.

About Radboud university medical centre
Radboud university medical center founded in 1951, is an institute for patient care, research and education & training, located in Nijmegen in the Netherlands. Our mission is to have a significant impact on healthcare. We aim to be a frontrunner in the development of innovative, sustainable and affordable healthcare. We offer excellent quality, participatory and personalised healthcare, operational excellence and sustainable networks. Our almost 10,000 employees and over 3,000 students do their utmost every day to make a positive contribution to the future of healthcare and medical sciences.

Most Popular Now

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Telehealth Significantly Boosts Treatmen…

New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both telemedicine and support from peers with lived experience in drug...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

AI can Predict Study Results Better than…

Large language models, a type of AI that analyses text, can predict the results of proposed neuroscience studies more accurately than human experts, finds a new study led by UCL...

New Guidance for Ensuring AI Safety in C…

As artificial intelligence (AI) becomes more prevalent in health care, organizations and clinicians must take steps to ensure its safe implementation and use in real-world clinical settings, according to an...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...

Shape-Changing Device Helps Visually Imp…

Researchers from Imperial College London, working with the company MakeSense Technology and the charity Bravo Victor, have developed a shape-changing device called Shape that helps people with visual impairment navigate...

Bayer Acquires HiDoc Technologies and Ca…

Bayer is today announcing that it plans to acquire HiDoc Technologies GmbH in the first quarter of 2025 and to start commercialization of the digital health application, Cara Care®. Cara...